← back to search

Dominik Niopek

Heidelberg University · DE
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include CRISPR and Genetic Engineering, RNA and protein synthesis mechanisms, Photoreceptor and optogenetics research, and Photosynthetic Processes and Mechanisms.
h-index
17
citations
1,751
works
64
NIH funding
primary concept
email

Recent publications

Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells
Science Signaling 2023cited by 5position: middledoi
Dynamics of SARS-CoV-2 host cell interactions inferred from transcriptome analyses
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
Science Advances 2020cited by 66position: lastdoi
Computational design of anti-CRISPR proteins with improved inhibition potency
Nature Chemical Biology 2020cited by 20position: lastdoi
Optogenetics and CRISPR: A New Relationship Built to Last
Methods in molecular biology 2020cited by 19position: lastdoi
Light-Inducible CRISPR Labeling
Methods in molecular biology 2020cited by 1position: lastdoi
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
Nucleic Acids Research 2019cited by 115position: lastdoi
Leveraging implicit knowledge in neural networks for functional dissection and engineering of proteins
Nature Machine Intelligence 2019cited by 27position: middledoi
Computational design of anti-CRISPR proteins with improved inhibition potency and expanded specificity
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 4position: lastdoi
Optogenetic control of <i>Neisseria meningitidis</i> Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 3position: lastdoi
Publisher Correction: Leveraging implicit knowledge in neural networks for functional dissection and engineering of proteins
Nature Machine Intelligence 2019cited by 0position: middledoi
Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9
Nature Methods 2018cited by 210position: lastdoi
AAV vector-mediated in vivo reprogramming into pluripotency
Nature Communications 2018cited by 64position: middledoi
A Robust and All-Inclusive Pipeline for Shuffling of Adeno-Associated Viruses
ACS Synthetic Biology 2018cited by 42position: middledoi
Controlling Cells with Light and LOV
Advanced Biosystems 2018cited by 32position: lastdoi
Cell-specific CRISPR/Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 17position: lastdoi
A Hepatic GAbp-AMPK Axis Links Inflammatory Signaling to Systemic Vascular Damage
Cell Reports 2017cited by 10position: middledoi
Optogenetic control of nuclear protein export
Nature Communications 2016cited by 265position: firstdoi
Optogenetic Control of Nuclear Protein Import in Living Cells Using Light‐Inducible Nuclear Localization Signals (LINuS)
Current Protocols in Chemical Biology 2016cited by 16position: middledoi
CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
Biotechnology Journal 2014cited by 265position: middledoi
Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells
Nature Communications 2014cited by 258position: firstdoi
Creating functional engineered variants of the single-module non-ribosomal peptide synthetase IndC by T domain exchange
Molecular BioSystems 2014cited by 49position: middledoi
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
Nucleic Acids Research 2013cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Roland Eils · University of Michigan16 papers (2014–2023)Mareike D. Hoffmann · University of Minnesota System12 papers (2018–2020)Dirk Grimm · Vector (United States)9 papers (2013–2020)Jan Mathony · Berlin Institute of Health at Charité - Universitätsmedizin Berlin8 papers (2019–2023)Sabine Aschenbrenner · Heidelberg University6 papers (2018–2020)Julius Upmeier zu Belzen · Berlin Institute of Health at Charité - Universitätsmedizin Berlin5 papers (2019–2020)Carolin Schmelas · University Hospital Heidelberg5 papers (2018–2020)Felix Bubeck · University Hospital Heidelberg5 papers (2018–2020)Ellen Wiedtke · University Hospital Heidelberg4 papers (2013–2018)Bruno E. Correia · Wyss Center for Bio and Neuroengineering4 papers (2018–2020)Barbara Di Ventura · University of Freiburg4 papers (2014–2016)Stefanie Große · University Hospital Heidelberg4 papers (2014–2019)Kathleen Börner · European Molecular Biology Organization4 papers (2013–2019) · 4 papers (2018–2020)Lukas Adam · Roche (Switzerland)4 papers (2019–2023)Christina Stengl · German Cancer Research Center3 papers (2019–2020)Julia Fakhiri · University Hospital Heidelberg3 papers (2018–2019) · 3 papers (2018–2019)Stefan M. Kallenberger · Heidelberg University3 papers (2020–2023)Pierre Wehler · University of Freiburg3 papers (2014–2016)